Found: 136
Select item for more details and to access through your institution.
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00816-w
- By:
- Publication type:
- Article
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2011, v. 14, n. 6, p. 756, doi. 10.1017/S1461145710001689
- By:
- Publication type:
- Article
Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99845-1
- By:
- Publication type:
- Article
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-98640-2
- By:
- Publication type:
- Article
Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 3, p. 412, doi. 10.3390/jpm12030412
- By:
- Publication type:
- Article
Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.984383
- By:
- Publication type:
- Article
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
- Published in:
- Nature Medicine, 1999, v. 5, n. 3, p. 347, doi. 10.1038/6568
- By:
- Publication type:
- Article
Symposium: What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD?
- Published in:
- Journal of Neuroscience, 2024, v. 44, n. 41, p. 1, doi. 10.1523/JNEUROSCI.1295-24.2024
- By:
- Publication type:
- Article
Metabolomics profiling reveals distinct, sex‐specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 3987, doi. 10.1002/alz.13851
- By:
- Publication type:
- Article
Sexual dimorphisms in longitudinal associations of the blood lipidome with cognitive decline in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082967
- By:
- Publication type:
- Article
A modified Mediterranean‐ketogenic diet favorably modulates the metabolic profiles of mild cognitively impaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079848
- By:
- Publication type:
- Article
Gut microbiome‐related metabolites in plasma are associated with general cognition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078299
- By:
- Publication type:
- Article
Bile acids inform about a sex‐specific resilience phenotype against Alzheimer's disease implicating a role for the gut microbiome and the exposome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078297
- By:
- Publication type:
- Article
Gut microbiome moderates the association between metabolic syndrome and the cerebrospinal fluid concentration of YKL‐40 in a cognitively unimpaired cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077952
- By:
- Publication type:
- Article
Correlational analysis of plasma metabolome and brain imaging in a humanized APOE mouse model.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080468
- By:
- Publication type:
- Article
Plasma metabolomic profiles of aged, humanized APOE mice and behavioral correlates.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080101
- By:
- Publication type:
- Article
Preclinical Alzheimer's disease is associated with distinct gut microbial metagenomic profiles.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073847
- By:
- Publication type:
- Article
Gut microbial composition mediates the relationship between intestinal inflammation and amyloid burden before cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078994
- By:
- Publication type:
- Article
Pseudo‐temporal models of Alzheimer's Disease progression across brain‐derived transcriptomics, proteomics, and metabolomics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080320
- By:
- Publication type:
- Article
Gut microbial families associate with brain volume in cognitively unimpaired aging adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077917
- By:
- Publication type:
- Article
An Integrative Multi‐Omics Approach Reveals Molecular Signatures Associated with Age and High‐Fat Diet in Mouse Models of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077260
- By:
- Publication type:
- Article
In silico prioritiziation of drug repositioning candidates for Alzheimer's disease using signature search meta‐analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076844
- By:
- Publication type:
- Article
Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.072776
- By:
- Publication type:
- Article
Gut microbial composition mediates the relationship between intestinal inflammation and amyloid burden before cognitive decline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081862
- By:
- Publication type:
- Article
Pseudo‐temporal models of Alzheimer's Disease progression across brain‐derived transcriptomics, proteomics, and metabolomics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080320
- By:
- Publication type:
- Article
Gut microbial families associate with brain volume in cognitively unimpaired aging adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077917
- By:
- Publication type:
- Article
An Integrative Multi‐Omics Approach Reveals Molecular Signatures Associated with Age and High‐Fat Diet in Mouse Models of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077260
- By:
- Publication type:
- Article
In silico prioritiziation of drug repositioning candidates for Alzheimer's disease using signature search meta‐analysis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076844
- By:
- Publication type:
- Article
Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.072776
- By:
- Publication type:
- Article
Effects of a ketogenic and low‐fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 4805, doi. 10.1002/alz.13007
- By:
- Publication type:
- Article
Evolution of circulating metabolites through lifespan according to gender and APOE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.067134
- By:
- Publication type:
- Article
Multi‐omics characterization of brain‐based pseudotime estimates for Alzheimer's disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065437
- By:
- Publication type:
- Article
Predictive metabolic networks reveal sex‐ and APOE genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 2, p. 518, doi. 10.1002/alz.12675
- By:
- Publication type:
- Article
The landscape of metabolic brain alterations in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 980, doi. 10.1002/alz.12714
- By:
- Publication type:
- Article
Bacteroides genus is associated with lower executive function in cognitively unimpaired participants.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.069291
- By:
- Publication type:
- Article
Associations between gut microbial families and brain myelin in a human cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069400
- By:
- Publication type:
- Article
Novel circling SWAT for deep learning based diagnostic classification of Alzheimer's disease: Application to metabolome data.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069310
- By:
- Publication type:
- Article
Interactions between brain and bile acid ratio profiles predict baseline cognitive status.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.067272
- By:
- Publication type:
- Article
Brain region‐specific metabolic signatures of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.067879
- By:
- Publication type:
- Article
Metabolomics profiling reveals distinct signatures in the serum and brain metabolomes in mouse models of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.064137
- By:
- Publication type:
- Article
Mapping the human brain metabolome and influences of gut microbiome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056270
- By:
- Publication type:
- Article
Profiling the metabolome of patients with dementia in the UK Biobank.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056147
- By:
- Publication type:
- Article
Transcriptomics, metabolomics, lipidomics, metabolic flux and mGWAS analyses of sphingolipid pathway highlights novel drugs for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056152
- By:
- Publication type:
- Article
Gut microbiome‐related metabolites in plasma are associated with general cognition.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056142
- By:
- Publication type:
- Article
A proof of concept study towards multi‐omics‐based computational drug repositioning in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056673
- By:
- Publication type:
- Article
Investigating the importance of acylcarnitines in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056647
- By:
- Publication type:
- Article
The metabolic landscape of brain alterations in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.054793
- By:
- Publication type:
- Article
Integrative metabolomics‐genomics approach reveals that pathways related to the metabolism of acylcarnitines and amines are new potential targets of Alzheimer's disease: Genome‐metabolome‐phenome: Towards an integrated molecular atlas for Alzheimer's disease
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045610
- By:
- Publication type:
- Article